CytomX Therapeutics, Inc. License Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Collaboration and License Agreement between CytomX Therapeutics, Inc. and Bristol-Myers Squibb Company
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
NJ
2020
Research Collaboration, Option and License Agreement between Pfizer Inc. and CytomX Therapeutics, Inc.
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
NY
2020
Amendment No.3 to Exclusive License Agreement effective as of April 2, 2019, by and between CytomX Therapeutics, Inc. and The Regents of the University of California
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2019
License Agreement Between CytomX Therapeutics, Inc. and ImmunoGen, Inc. Dated February 12, 2016
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
MA
2018
Third Amendment to CD71 Co-Development and License Agreement between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
Second Amendment to CD71 Co-Development and License Agreement between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018
First Amendment to CD71 Co-Development and License Agreement between CytomX Therapeutics, Inc. and AbbVie Ireland Unlimited Company
License Agreements
CytomX Therapeutics, Inc.
Biotechnology
2018